Geftinat 250 mg tablets (containing Gefitinib IP) are a targeted anti-cancer medication primarily used to treat adults with advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) who have specific EGFR mutations. It is a prescription-only medication manufactured by Natco Pharma.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Strength 250 mg
Brand Geftinat
Tablets per Pack 30 Tablets
Pack Type Bottle
Usage Lung Cancer, EGFR NSCLC, Metastatic NSCLC, NSCLC
Prescription/Non prescription Prescription
Manufactured By Natco
Form Tablet
Country of Origin Made in India
Composition Geftinib Tablets IP
Pack Size 30 tablets
Minimum order quantity: 50 Bottle
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.